| 國立成功大學 |
2023 |
A two-step culture process for generating abundant CD14+ monocytes from human hematopoietic stem cells
|
Tseng, Tseng T.-Y.;Lu, Lu L.-C.;Tsai, H.-F.;Hsu, K.-F.;Chuang, Chuang C.-M.;Wang, Y.-T.;Lai, Y.-T.;Yao, C.-L. |
| 國立成功大學 |
2023 |
Determinants of quality of life related to lower limb lymphedema in women with gynecological cancer surgery
|
Hsu, Y.-Y.;Liu, C.-Y.;Ho, C.-L.;Hsu, K.-F. |
| 國立成功大學 |
2022 |
An Integrated, Multiplex Digital PCR-Based Microfluidic System for Quantification of Two Microrna Biomarkers for Diagnosis of Ovarian Cancer
|
Huang, C.-C.;Sung, C.-Y.;Chen, Y.-S.;Hsu, K.-F.;Lee, G.-B. |
| 臺大學術典藏 |
2021-02-04T07:44:57Z |
Impact of management on the prognosis of pure uterine papillary serous cancer - A Taiwanese Gynecologic Oncology Group (TGOG) study
|
Huang C.-Y.;Tang Y.-H.;Ying-Cheng Chiang;Wang K.-L.;Fu H.-C.;Ke Y.-M.;Lau H.-Y.;Hsu K.-F.;Wu C.-H.;Cheng W.-F.; Huang C.-Y.; Tang Y.-H.; YING-CHENG CHIANG; Wang K.-L.; Fu H.-C.; Ke Y.-M.; Lau H.-Y.; Hsu K.-F.; Wu C.-H.; Cheng W.-F. |
| 國立成功大學 |
2021 |
Omental macrophagic “crown-like structures” are associated with poor prognosis in advanced-stage serous ovarian cancer
|
Liang, Y.-L.;Lin, C.-N.;Tsai, H.-F.;Wu, P.-Y.;Hsu, K.-F.;Lin, S.-H.;Hong, T.-M. |
| 國立成功大學 |
2021 |
An Integrated Microfluidic Platform for Detecting BRCA1/BRCA2 Gene Mutation and Risk Assessment of Ovarian Cancer
|
Cheng, Y.-H.;Wang, C.-H.;Hsu, K.-F.;Lee, G.-B. |
| 國立成功大學 |
2020-12-01 |
Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancer
|
林鵬展; Lin, P.-C.;Yeh, Y.-M.;Wu, P.-Y.;Hsu, K.-F.;Chang, J.-Y.;Shen, M.-R. |
| 臺大學術典藏 |
2020-05-24T06:00:20Z |
Risk factor analysis of coexisting endometrial carcinoma in patients with endometrial hyperplasia: A retrospective observational study of Taiwanese Gynecologic Oncology Group
|
Yen M.-S.; Hsu K.-F.; YU-LI CHEN; Wang K.-L.; Chen M.-Y.; Yu M.-H.; Wu C.-H.; Ke Y.-M.; Chen Y.-J.; Chang Y.-Y. |
| 臺大學術典藏 |
2020-03-31T08:25:23Z |
New metal chalcogenides found in Mn:N-1(Gd2-xInx)SN+2 (N = 3, 4, 5): Syntheses, structures, and magnetic properties
|
Liang, I. C.; Weng, C. Y.; Huang, C.; Chang, C. K.; Sheu, H. S.; Lin, J. G.; Hsu, K. F. |
| 臺大學術典藏 |
2020-02-14T08:50:34Z |
Impact of management on the prognosis of pure uterine papillary serous cancer - A Taiwanese Gynecologic Oncology Group (TGOG) study
|
Cheng W.-F.; Huang C.-Y; Tang Y.-H; YING-CHENG CHIANG; Wang K.-L; Fu H.-C; Ke Y.-M; Lau H.-Y; Hsu K.-F; Wu C.-H |
| 臺大學術典藏 |
2020-02-14T02:50:26Z |
Enhancement of Sindbis virus self-replicating RNA vaccine potency by linkage of herpes simplex virus type 1 VP22 protein to antigen
|
Wen-Fang Cheng;Hung C.-F.;Chai C.-Y.;Hsu K.-F.;He L.;Ling M.;Wu T.-C.; WEN-FANG CHENG; Hung C.-F.; Chai C.-Y.; Hsu K.-F.; He L.; Ling M.; Wu T.-C. |
| 臺大學術典藏 |
2020-02-14T02:50:25Z |
Cancer immunotherapy using a DNA vaccine encoding the translocation domain of a bacterial toxin linked to a tumor antigen
|
Hung C.-F.;Wen-Fang Cheng;Hsu K.-F.;Chai C.-Y.;He L.;Ling M.;Wu T.-C.; Hung C.-F.; WEN-FANG CHENG; Hsu K.-F.; Chai C.-Y.; He L.; Ling M.; Wu T.-C. |
| 臺大學術典藏 |
2020-02-14T02:50:25Z |
Enhancement of suicidal DNA vaccine potency by linking Mycobacterium tuberculosis heat shock protein 70 to an antigen
|
Hsu K.-F.;Hung C.-F.;Wen-Fang Cheng;He L.;Slater L.A.;Ling M.;Wu T.-C.; Hsu K.-F.; Hung C.-F.; WEN-FANG CHENG; He L.; Slater L.A.; Ling M.; Wu T.-C. |
| 臺大學術典藏 |
2020-02-14T02:50:23Z |
Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen
|
Wen-Fang Cheng;Hung C.-F.;Chai C.-Y.;Hsu K.-F.;He L.;Ling M.;Wu T.-C.; WEN-FANG CHENG; Hung C.-F.; Chai C.-Y.; Hsu K.-F.; He L.; Ling M.; Wu T.-C. |
| 臺大學術典藏 |
2020-02-14T02:50:23Z |
Enhancement of sindbis virus self-replicating RNA vaccine potency by linkage of Mycobacterium tuberculosis heat shock protein 70 gene to an antigen gene
|
Wu T.-C.; Ling M.; Rice C.M.; He L.; Hsu K.-F.; Wen-Fang Cheng;Hung C.-F.;Chai C.-Y.;Hsu K.-F.;He L.;Rice C.M.;Ling M.;Wu T.-C.; WEN-FANG CHENG; Hung C.-F.; Chai C.-Y. |
| 臺大學術典藏 |
2020-02-14T02:50:22Z |
Repeated DNA vaccinations elicited qualitatively different cytotoxic T lymphocytes and improved protective antitumor effects
|
Wen-Fang Cheng;Hung C.F.;Pai S.I.;Hsu K.F.;He L.;Ling M.;Wu T.C.; WEN-FANG CHENG; Hung C.F.; Pai S.I.; Hsu K.F.; He L.; Ling M.; Wu T.C. |
| 臺大學術典藏 |
2020-02-14T02:50:21Z |
Cancer immunotherapy using sindbis virus replicon particles encoding a VP22-antigen fusion
|
Wen-Fang Cheng;Hung C.-F.;Hsu K.-F.;Chai C.-Y.;He L.;Polo J.M.;Slater L.A.;Ling M.;Wu T.-C.; WEN-FANG CHENG; Hung C.-F.; Hsu K.-F.; Chai C.-Y.; He L.; Polo J.M.; Slater L.A.; Ling M.; Wu T.-C. |
| 臺大學術典藏 |
2020-02-14T02:49:49Z |
Circulating IGF system and treatment outcome in epithelial ovarian cancer
|
Chou C.-Y.; Hsu K.-F.; Cheng Y.-M.; Wu Y.-P.; WEN-FANG CHENG; Huang Y.-F.; Huang Y.-F.;Wen-Fang Cheng;Wu Y.-P.;Cheng Y.-M.;Hsu K.-F.;Chou C.-Y. |
| 臺大學術典藏 |
2020-02-14T02:49:48Z |
Prognostic factors and treatment outcomes for patients with surgically staged uterine clear cell carcinoma focusing on the early stage: A Taiwanese Gynecologic Oncology Group study
|
Hsu K.-F.; Chou H.-H.; Huang C.-Y.; Fu H.-C.; Chiang A.-J.; Tsai H.-W.; Chen J.-R.; WEN-FANG CHENG; Ke Y.-M.; Chang C.-C.; Chen T.-H.; Lin S.-H.; Ho C.-M. |
| 臺大學術典藏 |
2020-02-14T02:49:38Z |
Treatment outcomes of patients with stage II pure endometrioid-type endometrial cancer: A Taiwanese Gynecologic Oncology Group (TGOG-2006) retrospective cohort study
|
Fu H.-C.;Chen J.-R.;Chen M.-Y.;Hsu K.-F.;Wen-Fang Cheng;Chiang A.-J.;Ke Y.-M.;Chen Y.-C.;Chang Y.-Y.;Huang C.-Y.;Kang C.-Y.;Kan Y.-Y.;Hsiao S.-M.;Yen M.-S.; Fu H.-C.; Chen J.-R.; Chen M.-Y.; Hsu K.-F.; WEN-FANG CHENG; Chiang A.-J.; Ke Y.-M.; Chen Y.-C.; Chang Y.-Y.; Huang C.-Y.; Kang C.-Y.; Kan Y.-Y.; Hsiao S.-M.; Yen M.-S. |
| 臺大學術典藏 |
2020-02-06T05:22:47Z |
Enhancement of Sindbis virus self-replicating RNA vaccine potency by linkage of herpes simplex virus type 1 VP22 protein to antigen
|
Wu T.-C.;Ling M.;He L.;Hsu K.-F.;Chai C.-Y.;Hung C.-F.;WEN-FANG CHENG; WEN-FANG CHENG; Hung C.-F.; Chai C.-Y.; Hsu K.-F.; He L.; Ling M.; Wu T.-C.; WEN-FANG CHENG; Hung C.-F.; Chai C.-Y.; Hsu K.-F.; He L.; Ling M.; Wu T.-C. |
| 臺大學術典藏 |
2020-02-06T05:22:47Z |
Enhancement of sindbis virus self-replicating RNA vaccine potency by targeting antigen to endosomal/lysosomal compartments
|
Wu T.-C.;Roden R.B.S.;Slater L.A.;Ling M.;He L.;Chai C.-Y.;Hsu K.-F.;Hung C.-F.;WEN-FANG CHENG; WEN-FANG CHENG; Hung C.-F.; Hsu K.-F.; Chai C.-Y.; He L.; Ling M.; Slater L.A.; Roden R.B.S.; Wu T.-C.; WEN-FANG CHENG; Hung C.-F.; Hsu K.-F.; Chai C.-Y.; He L.; Ling M.; Slater L.A.; Roden R.B.S.; Wu T.-C. |
| 臺大學術典藏 |
2020-02-06T05:22:46Z |
Enhancement of DNA vaccine potency by linkage of antigen gene to a gene encoding the extracellular domain of Fms-like tyrosine kinase 3-ligand
|
Wu T.-C.;Ling M.;He L.;Chai C.-Y.;WEN-FANG CHENG;Hsu K.-F.;Hung C.-F.; Hung C.-F.; Hsu K.-F.; WEN-FANG CHENG; Chai C.-Y.; He L.; Ling M.; Wu T.-C.; Hung C.-F.; Hsu K.-F.; WEN-FANG CHENG; Chai C.-Y.; He L.; Ling M.; Wu T.-C. |
| 臺大學術典藏 |
2020-02-06T05:22:45Z |
Improving vaccine potency through intercellular spreading and enhanced MHC class I presentation of antigen
|
Wu T.-C.;Ling M.;He L.;Hsu K.-F.;Chai C.-Y.;WEN-FANG CHENG;Hung C.-F.; Hung C.-F.; WEN-FANG CHENG; Chai C.-Y.; Hsu K.-F.; He L.; Ling M.; Wu T.-C.; Hung C.-F.; WEN-FANG CHENG; Chai C.-Y.; Hsu K.-F.; He L.; Ling M.; Wu T.-C. |
| 臺大學術典藏 |
2020-02-06T05:22:45Z |
Cancer immunotherapy using a DNA vaccine encoding the translocation domain of a bacterial toxin linked to a tumor antigen
|
Wu T.-C.;Ling M.;He L.;Chai C.-Y.;Hsu K.-F.;WEN-FANG CHENG;Hung C.-F.; Hung C.-F.; WEN-FANG CHENG; Hsu K.-F.; Chai C.-Y.; He L.; Ling M.; Wu T.-C.; Hung C.-F.; WEN-FANG CHENG; Hsu K.-F.; Chai C.-Y.; He L.; Ling M.; Wu T.-C. |
